IL1B and acute respiratory distress syndrome: Numerous studies have shown that GLN has immune modulation properties, as it attenuates the release of TNF-α, IL-1β, IL-6, and IL-8 in response to oxidative stress, and prevents lung injury along with improved outcomes in ARDS [14,15,16,17,18].